drugset / Trial / NCT01241461
A Study of LY2584702 in Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the safety and tolerability of LY2584702 in Japanese patients with advanced and/or metastatic solid tumors for which no proven effective therapy exists.
Timeline
- Start
- 2010-11
- Primary completion
- 2011-11
- Completion
- 2011-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LY2584702 | Small molecule | 50 mg | Oral |